<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04566601</url>
  </required_header>
  <id_info>
    <org_study_id>1402-0012</org_study_id>
    <secondary_id>2020-000078-12</secondary_id>
    <nct_id>NCT04566601</nct_id>
  </id_info>
  <brief_title>A Study to Test Different Doses of BI 1358894 and Find Out Whether They Reduce Symptoms in People With Borderline Personality Disorder</brief_title>
  <official_title>A Phase II Randomized, Double-blinded, Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of 4 Oral Doses of BI 1358894 Once Daily Over 12 Week Treatment Period in Patients With Borderline Personality Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boehringer Ingelheim</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boehringer Ingelheim</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is open to adults with borderline personality disorder. The purpose of this study&#xD;
      is to find out whether a medicine called BI 1358894 helps to reduce symptoms in people with&#xD;
      borderline personality disorder. Four different doses of BI 1358894 are tested in the study.&#xD;
&#xD;
      Participants are put into 5 groups by chance. Participants in 4 of the 5 groups take&#xD;
      different doses of BI 1358894. Participants in the fifth group take placebo. Participants&#xD;
      take BI 1358894 and placebo as tablets once a day. Placebo tablets look like BI 1358894&#xD;
      tablets but do not contain any medicine.&#xD;
&#xD;
      Participants are in the study for about 5 months. During this time, they visit the study site&#xD;
      about 12 times and get about 6 phone calls. At the visits, doctors ask participants about&#xD;
      their symptoms. The results between the BI 1358894 groups and the placebo group are then&#xD;
      compared. The doctors also regularly check the general health of the participants.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 13, 2020</start_date>
  <completion_date type="Anticipated">January 19, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 8, 2022</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in Zanarini rating scale for Borderline personality disorder (ZAN-BPD) total score at Week 10</measure>
    <time_frame>Baseline and week 10</time_frame>
    <description>The ZAN-BPD scale reflects the nine disease criteria with each one rated on a 5-point rating scale. The total ZAN-BPD score ranges from 0 to 36 with higher scores reflecting greater levels of symptoms. The ZAN-BPD scale is administered as an interview.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Response defined as ≥30% ZAN-BPD reduction from baseline at Week 10.</measure>
    <time_frame>Baseline and week 10</time_frame>
    <description>The ZAN-BPD scale reflects the nine disease criteria with each one rated on a 5-point rating scale. The total ZAN-BPD score ranges from 0 to 36 with higher scores reflecting greater levels of symptoms. The ZAN-BPD scale is administered as an interview.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Difficulties in Emotion Regulation Scale (DERS-16) total score at Week 10</measure>
    <time_frame>Baseline and week 10</time_frame>
    <description>The DERS-16 total score ranges from 16 to 80 with higher scores reflecting greater levels of emotional dysregulation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in State-Trait Anxiety Inventory (STAI-S) total score at Week 10.</measure>
    <time_frame>Baseline and week 10</time_frame>
    <description>The STAI-S total score ranges from 20 to 80 with higher scores indicating higher anxiety.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Patient Health Questionnaire (PHQ-9) total score at Week 10.</measure>
    <time_frame>Baseline and week 10</time_frame>
    <description>The PHQ-9 total score ranges from 0 to 27 with higher scores indicating higher depression severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Clinical Global Impression Severity scale (CGI-S) at Week 10</measure>
    <time_frame>Baseline and week 10</time_frame>
    <description>The CGI-S score ranges from 1 to 7 with higher scores indicating worsening of the patient's illness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Patient Global Impression Severity scale (PGI-S) at Week 10.</measure>
    <time_frame>Baseline and week 10</time_frame>
    <description>The PGI-S score ranges from 1 to 5 with higher scores indicating worsening of the patients's symptoms.</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">355</enrollment>
  <condition>Borderline Personality Disorder</condition>
  <arm_group>
    <arm_group_label>BI 1358894 dose group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>BI 1358894 dose group 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>BI 1358894 dose group 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>BI 1358894 dose group 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>BI 1358894</intervention_name>
    <description>Film-coated tablet</description>
    <arm_group_label>BI 1358894 dose group 1</arm_group_label>
    <arm_group_label>BI 1358894 dose group 2</arm_group_label>
    <arm_group_label>BI 1358894 dose group 3</arm_group_label>
    <arm_group_label>BI 1358894 dose group 4</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Film-coated tablet</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients meeting diagnostic criteria of borderline personality disorder (BoPD) per&#xD;
             Diagnostic and Statistical Manual of Mental Disorders(DSM-5) at screening visit,&#xD;
             confirmed by Structured Interview for DSM-5 Personality Disorder (SCID-5-PD).&#xD;
&#xD;
          -  Zanarini rating scale for Borderline personality disorder (ZAN-BPD) of ≥ 9 at&#xD;
             screening (Visit 1) and randomization (Visit 2), with question #2 Affective&#xD;
             Instability score of ≥2.&#xD;
&#xD;
          -  Male or female patients, 18-65 years of age at the time of consent&#xD;
&#xD;
          -  Women of childbearing potential (WOCBP)1 able and willing to use two methods of&#xD;
             contraception, which include one highly effective method of birth control per ICH M3&#xD;
             (R2) that results in a low failure rate of less than 1%, plus one barrier method.&#xD;
&#xD;
          -  Signed and dated written informed consent in accordance with International Council on&#xD;
             Harmonization (ICH) - Good Clinical Practice (GCP) and local legislation prior to&#xD;
             admission to the trial.&#xD;
&#xD;
          -  further inclusion criteria apply.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current diagnosis of paranoid, schizoid, schizotypal and antisocial personality&#xD;
             disorders, as confirmed by SCID-5-PD at screening visit.&#xD;
&#xD;
          -  Lifetime diagnosis for schizophrenia, schizoaffective disorder, schizophreniform&#xD;
             disorder, bipolar I disorder, or delusional disorder as confirmed by the SCID-5 at the&#xD;
             screening visit.&#xD;
&#xD;
          -  Any other mental disorder that is the primary focus of treatment in the last 6 months&#xD;
             prior to randomization, as per the clinical judgement of the investigator.&#xD;
&#xD;
          -  Inpatient stay or hospitalization due to worsening of BoPD within 3 months prior to&#xD;
             randomization.&#xD;
&#xD;
          -  Initiation or change in any type or frequency of psychotherapy for BoPD within the&#xD;
             last 3 months prior to randomization.&#xD;
&#xD;
          -  Any ongoing use of psychotropic medications within 7 days prior to randomization or&#xD;
             during the course of study.&#xD;
&#xD;
          -  Any suicidal behavior in the past 1 year.&#xD;
&#xD;
          -  Any suicidal ideation of type 4 or 5 in the Columbia Suicidal Severity Rating Scale&#xD;
             (C-SSRS) in the past 3 months.&#xD;
&#xD;
          -  furhter exclusion criteria apply.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Boehringer Ingelheim</last_name>
    <phone>1-800-243-0127</phone>
    <email>clintriage.rdg@boehringer-ingelheim.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Viking Clinical Research, Ltd.</name>
      <address>
        <city>Temecula</city>
        <state>California</state>
        <zip>00000</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sana Johnson-Quijada</last_name>
      <phone>+001(951)695-6238</phone>
      <email>sana@vikingcr.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pacific Clinical Research Management Group LLC</name>
      <address>
        <city>Upland</city>
        <state>California</state>
        <zip>00000</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sameer Hassamal</last_name>
      <phone>+001(909)920-3000</phone>
      <email>shassamal@pcrmg.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Yale University School of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>00000</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Fineberg</last_name>
      <phone>+001(203)974-7265</phone>
      <email>sarah.fineberg@yale.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gulf Coast Clinical Research Center</name>
      <address>
        <city>Fort Myers</city>
        <state>Florida</state>
        <zip>00000</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zaheer Aslam</last_name>
      <phone>+001(239)561-0009</phone>
      <email>Aslam@gulfcoastclinicalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sarkis Clinical Trials</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>00000</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elias Sarkis</last_name>
      <phone>+001(352)333-0094</phone>
      <email>ok@ehsfamily.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>San Marcus Research Clinic, Inc.</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>00000</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy Navarro Gonzalez</last_name>
      <phone>+001(305)424-7420</phone>
      <email>nnavarro@sanmarcusrc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institute for Advanced Medical Research</name>
      <address>
        <city>Alpharetta</city>
        <state>Georgia</state>
        <zip>00000</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angelo Sambunaris</last_name>
      <phone>+001(770)817-9200</phone>
      <email>a.sambunaris@iamresearch.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>McLean Hospital</name>
      <address>
        <city>Belmont</city>
        <state>Massachusetts</state>
        <zip>00000</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Zanarini</last_name>
      <phone>+001(617)855-2660</phone>
      <email>zanarini@mclean.harvard.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Precise Research Centers</name>
      <address>
        <city>Flowood</city>
        <state>Mississippi</state>
        <zip>00000</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph Kwentus</last_name>
      <phone>+001(601)420-5810</phone>
      <email>jkwentus@precise-research.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University at Buffalo, The State University of New York</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>00000</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven Dubovsky</last_name>
      <phone>+001(716)898-5940</phone>
      <email>dubovsky@buffalo.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Neurobehavioral Research, Inc.</name>
      <address>
        <city>Cedarhurst</city>
        <state>New York</state>
        <zip>00000</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronald Brenner</last_name>
      <phone>+001(516)295-7230</phone>
      <email>rbrenner@nbrresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Central States Research, LLC</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>00000</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Land</last_name>
      <phone>+001(918)645-5400</phone>
      <email>sarah.land@centralstatesresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Grayline Research Center</name>
      <address>
        <city>Wichita Falls</city>
        <state>Texas</state>
        <zip>00000</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benny Barnhart</last_name>
      <phone>+001(940)322-1131</phone>
      <email>barnhart@graylinecdt.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Core Clinical Research</name>
      <address>
        <city>Everett</city>
        <state>Washington</state>
        <zip>00000</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Knutson</last_name>
      <phone>+001(425)443-9551</phone>
      <email>drjames.knutson@etresource.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fundación FunDaMos para la asistencia e investigación en psiquiatr</name>
      <address>
        <city>Caba</city>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Mosca</last_name>
      <phone>+541149038776</phone>
      <email>danimosca07@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fundación para el Estudio y Tratamiento de las Enfermedades Mentales (F</name>
      <address>
        <city>Caba</city>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ricardo Corral</last_name>
      <phone>+541143040031</phone>
      <email>rcorral33@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CEN (Centro Especializado Neurociencias)</name>
      <address>
        <city>Cordoba</city>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hernán Ruggeri</last_name>
      <phone>+5435153339477</phone>
      <email>drruggerihernan@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instituto Médico DAMIC S.R.L.</name>
      <address>
        <city>Cordoba</city>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerardo García Bonetto</last_name>
      <phone>+5493516508068</phone>
      <email>gerardo@garciabonetto.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instituto Modelo de Neurología Lennox</name>
      <address>
        <city>Córdoba</city>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georgina Viczena</last_name>
      <phone>+543514235128</phone>
      <email>gviczena2002@yahoo.com.ar</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinica Privada de Salud Mental Santa Teresa de Avila</name>
      <address>
        <city>La Plata</city>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hernán Alessandria</last_name>
      <phone>+542214233606</phone>
      <email>alesalud74@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instituto de Neurociencias San Agustín</name>
      <address>
        <city>La Plata</city>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Héctor Lamaison</last_name>
      <phone>+542214538862</phone>
      <email>hflamaison@yahoo.com.ar</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro de Investigacion y Asistencia en Psiquiatria (CIAP)</name>
      <address>
        <city>Rosario</city>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Lupo</last_name>
      <phone>+543414475652</phone>
      <email>christianlupo@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Peninsula Therapeutic and Research Group</name>
      <address>
        <city>Frankston</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Grunfeld</last_name>
      <phone>0397701579</phone>
      <email>jgrunfeld@ptrg.com.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Monash Alfred Psychiatry Research Centre</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leonard Chen</last_name>
      <phone>0390766554</phone>
      <email>leonard.chen@monash.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitair Psychiatrisch Centrum Duffel (UPC Duffel)</name>
      <address>
        <city>Duffel</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Livia De Picker</last_name>
      <phone>+3215303671</phone>
      <email>livia.depicker@emmaus.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical Center Intermedica Ltd.</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tony Donchev</last_name>
      <phone>+35929225574</phone>
      <email>tonyd@abv.bg</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Multiprofile Hospital 'Alexandrovska', Sofia</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georgi Onchev</last_name>
      <phone>+35929230680</phone>
      <email>georgi.onchev@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>DCC Mladost-M Varna OOD</name>
      <address>
        <city>Varna</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Petar Petrov</last_name>
      <phone>+35952301677</phone>
      <email>pmdown@abv.bg</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Institute of Mental Health</name>
      <address>
        <city>Klecany</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jirina Kosova</last_name>
      <phone>+420283088282</phone>
      <email>jirina.kosova@nudz.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>A-shine</name>
      <address>
        <city>Plzen</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lubos Janu</last_name>
      <phone>+420777242101</phone>
      <email>lubos.janu@seznam.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clintrial s.r.o.</name>
      <address>
        <city>Prague</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zdenek Solle</last_name>
      <phone>+420602179709,420222510607</phone>
      <email>zdenek.solle@clintrial.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>INEP medical s.r.o.</name>
      <address>
        <city>Prague</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Nawka</last_name>
      <phone>+420222201020</phone>
      <email>a.nawka@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aalborg Universitetsshospital</name>
      <address>
        <city>Aalborg</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>René Nielsen</last_name>
      <phone>+4597643595</phone>
      <email>ren@rn.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Region Zealand, Psychiatric Research Unit</name>
      <address>
        <city>Slagelse</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erik Simonsen</last_name>
      <phone>+4558536071</phone>
      <email>es@regionsjaelland.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HOP Pierre Wertheimer</name>
      <address>
        <city>Bron</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed Saoud</last_name>
      <phone>+33(0)472118064</phone>
      <email>mohamed.saoud@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HOP la Colombière</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Déborah Ducasse</last_name>
      <phone>+33(0)467330542</phone>
      <email>d-ducasse@chu-montpellier.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Charité - Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Röpke</last_name>
      <phone>+49(30)450517545</phone>
      <email>stefan.roepke@charite.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Bonn AöR</name>
      <address>
        <city>Bonn</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandra Philipsen</last_name>
      <phone>+49(228)287-15723</phone>
      <email>alexandra.philipsen@ukbonn.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Gießen und Marburg GmbH</name>
      <address>
        <city>Gießen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Mulert</last_name>
      <phone>+49(641)98545702</phone>
      <email>Christoph.Mulert@uk-gm.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Magdeburg AöR</name>
      <address>
        <city>Magdeburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Frodl</last_name>
      <phone>+49(241)8089632</phone>
      <email>tfrodl@ukaachen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zentralinstitut für seelische Gesundheit</name>
      <address>
        <city>Mannheim</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Schmahl</last_name>
      <phone>+49(621)1703-4021</phone>
      <email>christian.schmahl@zi-mannheim.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum der Universität München - Campus Innenstadt</name>
      <address>
        <city>München</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Musil</last_name>
      <phone>+49(89)4400-55888</phone>
      <email>Richard.Musil@med.uni-muenchen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Tübingen</name>
      <address>
        <city>Tübingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Ethofer</last_name>
      <phone>+49(7071)2982684</phone>
      <email>thomas.ethofer@med.uni-tuebingen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beer Sheva Mental Health Center</name>
      <address>
        <city>Beer Sheva</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriel Schreiber</last_name>
      <phone>(+972)8-6401770</phone>
      <email>gabriel.schreiber@PBSH.HEALTH.GOV.IL</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>IRCCS San Giovanni Di Dio Fatebenefratelli</name>
      <address>
        <city>Brescia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberta Rossi</last_name>
      <phone>+39(030)35011</phone>
      <email>rrossi@fatebenefratelli.eu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ASST degli Spedali Civili di Brescia</name>
      <address>
        <city>Concesio (BS)</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Vita</last_name>
      <phone>+39(030)2184856</phone>
      <email>antonio.vita@unibs.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>A.O.U. Senese Policlinico Santa Maria alle Scotte</name>
      <address>
        <city>Siena</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Fagiolini</last_name>
      <phone>+39(0577)585341</phone>
      <email>andreafagiolini@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hirota Clinic</name>
      <address>
        <city>Fukuoka, Kurume</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susumu Hirota</last_name>
      <phone>+81942372595</phone>
      <email>ponhiro21@yahoo.co.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kishiro Mental Clinic</name>
      <address>
        <city>Kanagawa, Kawasaki</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Masaki Kishiro</last_name>
      <phone>+81449301231</phone>
      <email>kishiro@kishiro-mental.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hiyoshi Hospital</name>
      <address>
        <city>Kanagawa, Yokohama</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Taro Ikawa</last_name>
      <phone>+81455637373</phone>
      <email>t-ikawa@hiyoshi-hp.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nara Medical University Hospital</name>
      <address>
        <city>Nara, Kashihara</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manabu Makinodan</last_name>
      <phone>+81744223051</phone>
      <email>mmm@naramed-u.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical Care and Research SA de CV</name>
      <address>
        <city>Merida</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miguel Viveros Erosa</last_name>
      <phone>+529999203879</phone>
      <email>miguelaviveroserosa@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CIT-Neuropsique S.C</name>
      <address>
        <city>Monterrey</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erasmo Saucedo Uribe</last_name>
      <phone>+52(81)1769.4050</phone>
      <email>drerasmosaucedo@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Dr Jose Eleuterio Gonzalez</name>
      <address>
        <city>Monterrey</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mario Caceres Vargas</last_name>
      <phone>+528181239532</phone>
      <email>marioh.caceresvargas@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro de Estudios Clinicos de Queretaro S.C</name>
      <address>
        <city>Queretaro</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miguel Rangel Alvarado</last_name>
      <phone>+52(442)2153067</phone>
      <email>maarangel@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>BIND Investigaciones S.C.</name>
      <address>
        <city>San Luis Potosi</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriel Alejo Galarza</last_name>
      <phone>+524442433135</phone>
      <email>gabriel_alejo@msn.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Podlassian Center of Psychogeriatry, Bialystok</name>
      <address>
        <city>Bialystok</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacek Dobryniewski</last_name>
      <phone>+48856610298</phone>
      <email>jacekdobryniewski@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>PI HOUSE Sp. z o.o., Gdansk</name>
      <address>
        <city>Gdansk</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katarzyna Binkowska-Michalik</last_name>
      <phone>+48587192222</phone>
      <email>k.binkmich@pihouse.pl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Clinical Center, Gdansk</name>
      <address>
        <city>Gdansk</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wieslaw Cubala</last_name>
      <phone>+48587270505,48583492650</phone>
      <email>cubala@gumed.edu.pl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Specialist Psychiatric Healthcare Centre in Lodz</name>
      <address>
        <city>Lodz</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Piotr Galecki</last_name>
      <phone>+48427155985</phone>
      <email>piotr.galecki@umed.lodz.pl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Ramón y Cajal</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>José Manuel Montes</last_name>
      <phone>+34913368000</phone>
      <email>j_m_montes@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Puerta de Hierro</name>
      <address>
        <city>Majadahonda</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rosario de Arce</last_name>
      <phone>+34911916523</phone>
      <email>rosario.arce@salud.madrid.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Marqués de Valdecilla</name>
      <address>
        <city>Santander</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Javier Vázquez</last_name>
      <phone>+34942202545</phone>
      <email>javazquez@humv.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CS Casa del Barco</name>
      <address>
        <city>Valladolid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manuel Franco</last_name>
      <phone>+34722801373</phone>
      <email>mfrancom@saludcastillayleon.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Psykiatri Södra Stockholm</name>
      <address>
        <city>Enskede</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giulia Arslan</last_name>
      <phone>+46812368163</phone>
      <email>giulia.arslan@sll.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska Universitetssjukhuset, Östra</name>
      <address>
        <city>Göteborg</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuseppe Guerriero</last_name>
      <phone>+46-31-3434000</phone>
      <email>giuseppe.guerriero@vgregion.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Akademiska sjukhuset</name>
      <address>
        <city>Uppsala</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Efthymios Kouppis</last_name>
      <phone>+46186110000</phone>
      <email>efthymios.kouppis@akademiska.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Belgium</country>
    <country>Bulgaria</country>
    <country>Czechia</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Mexico</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mystudywindow.com/</url>
    <description>Related Info</description>
  </link>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>September 23, 2020</study_first_submitted>
  <study_first_submitted_qc>September 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2020</study_first_posted>
  <last_update_submitted>November 17, 2021</last_update_submitted>
  <last_update_submitted_qc>November 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Personality Disorders</mesh_term>
    <mesh_term>Borderline Personality Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>After the study is completed and the primary manuscript is accepted for publishing, researchers can use this following link https://www.mystudywindow.com/msw/datasharing to request access to the clinical study documents regarding this study, and upon a signed &quot;Document Sharing Agreement&quot;. Also, Researchers can use the following link https://www.mystudywindow.com/msw/datasharing to find information in order to request access to the clinical study data, for this and other listed studies, after the submission of a research proposal and according to the terms outlined in the website. The data shared are the raw clinical study data sets.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>After all regulatory activities are completed in the US and EU for the product and indication, and after the primary manuscript has been accepted for publication.</ipd_time_frame>
    <ipd_access_criteria>For study documents - upon signing of a 'Document Sharing Agreement'.For study data - 1. after the submission and approval of the research proposal (checks will be performed by both the independent review panel and the sponsor, including checking that the planned analysis does not compete with sponsor's publication plan); 2. and upon signing of a 'Data Sharing Agreement'.</ipd_access_criteria>
    <ipd_url>https://www.mystudywindow.com/msw/datasharing</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

